This Tribe’s Blood Changed How Scientists Think About Aging After 70

For adults 70 and over: A population in the Bolivian Amazon barely shows any rise in inflammation with age, despite constant infections and no modern medicine. In industrialized populations, this kind of chronic inflammation, called inflammaging, climbs steadily every decade. In this video for people over 70, we break down a major 2026 review: the four biological engines driving inflammaging, what population and animal research reveals about how modifiable it is, what blood tests can now measure, what trials of senolytics, rapamycin, and metformin found, and what you can do today after 70. Chapters (approximate, adjust after your final edit): 0:00 A tribe that doesn’t get “old age” inflammation 1:20 Part 1: A fire with no injury to explain it 2:20 Part 2: Four engines, all running at once 3:50 Part 3: Why the Tsimane change the whole story 5:00 Part 4: Reading the fire from a blood draw 6:00 Part 5: What happens when scientists try to put the fire out 7:45 Part 6: The drug nobody expected 8:10 Part 7: What you can actually do after 70 9:10 The rule that ties this together This video is for educational purposes only and is not medical advice. Senolytics, senomorphics, and the other interventions discussed in this video are investigational or require medical supervision; do not start any new medication, supplement, or significant dietary change, including caloric restriction, without talking to your doctor. Research referenced in this video: Cossarizza A. Inflammaging: Experimental Insights and Translational Advances. European Journal of Immunology. 2026;56:e70239. DOI: 10.1002/eji.70239 (open access). Franck M, Tanner KT, Tennyson RL, et al. Nonuniversality of inflammaging across human populations. Nature Aging. 2025;5(8):1471-1480. Pinti M, Gibellini L, Lo Tartaro D, et al. A comprehensive analysis of cytokine network in centenarians. International Journal of Molecular Sciences. 2023;24(3):2719. Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554-563. Lee E, Carreras-Gallo N, Lopez L, et al. Exploring the effects of dasatinib, quercetin, and fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions. Aging. 2024;16(4):3088-3106. Lee DJW, Hodzic Kuerec A, Maier AB. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. The Lancet Healthy Longevity. 2024;5(2):e152-e162. Witham MD, McDonald C, Wilson N, et al. Metformin and physical performance in older people with probable sarcopenia (MET-PREVENT). Lancet Healthy Longevity. 2025;6(3):100695. Westbrook R, Chung T, Lovett J, et al. Kynurenines link chronic inflammation to functional decline and physical frailty. JCI Insight. 2020;5(16):e136091. Ortiz GU, de Freitas EC. Semaglutide as a possible therapy for healthy aging: targeting the hallmarks of aging. Ageing Research Reviews. 2024;102:102582. Hashtags: #After70 #Over70 #Inflammaging #CellularSenescence #Senolytics #HealthyAging #LongevityResearch Tags: inflammaging after 70, health after 70, aging after 70, healthy aging over 70, cellular senescence, SASP, Tsimane population aging, senolytics dasatinib quercetin, fisetin, rapamycin aging, metformin MET-PREVENT, biological aging clocks, kynurenine frailty, GLP-1 aging, centenarian inflammation, aging research 2026 Comment: Did the Tsimane comparison surprise you as much as it surprised me? Let me know below, especially if you’re over 70.